Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02361855

Ligand	Ligand name	Chain	PDB	Tanimoto
LPF	1,1,1-TRIFLUORO-3-((N-ACETYL)-L-LEUCYLAMIDO)-4-PHENYL-BUTAN-2-ONE(N-ACETYL-L-LEUCYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE)	G	7GCH	0.71
5FH	(5S)-5-benzylimidazolidine-2,4-dione	A	2JLO	0.74
53U	D-phenylalanyl-N-benzyl-L-prolinamide	H,I	2ZFF	0.7
PLH	METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID	A	1HFC	0.7
PLH	METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID	A	1MNC	0.7
0G6	D-phenylalanyl-N-[(1S)-4-{[amino(iminio)methyl]amino}-1-(chloroacetyl)butyl]-L-prolinamide	B,H,L	3DD2	0.71
0G6	D-phenylalanyl-N-[(1S)-4-{[amino(iminio)methyl]amino}-1-(chloroacetyl)butyl]-L-prolinamide	B,D,F,H	1XMN	0.71
CST	[[PHENYLALANINE-CARBONYL-AMINO-2-(2-AMINO-1,4,5,6-TETRAHYDRO-PYRIMIDIN-4-YL)-1-ACETALDEHYDYL]-2-ISOBUTYL-GLYCYL]PHENYLALANINE	A,B	1BCS	0.72
CST	[[PHENYLALANINE-CARBONYL-AMINO-2-(2-AMINO-1,4,5,6-TETRAHYDRO-PYRIMIDIN-4-YL)-1-ACETALDEHYDYL]-2-ISOBUTYL-GLYCYL]PHENYLALANINE	A	1SGC	0.72
DI5	AC-(D)PHE-PRO-BOROHOMOORNITHINE-OH	H	1LHG	0.72
FAF	2-ACETYLAMINO-4-METHYL-PENTANOIC ACID (1-FORMYL-2-PHENYL-ETHYL)-AMIDE	B,C	1GGD	0.72
MIN	METHYL-PHE-PRO-AMINO-CYCLOHEXYLGLYCINE	H,I	1TOM	0.72
357	5-ETHYL-3-[(2-METHOXYETHYL)METHYLAMINO]-6-METHYL-4-(3-METHYLBENZYL)PYRIDIN-2(1H)-ONE	A	2BAN	0.72
D7P	D-PHENYLALANYL-N~5~-[(2,2-DIHYDROXYHYDRAZINO)(IMINO)METHYL]-D-ORNITHINAMIDE	A,B	1RS7	0.75
D7P	D-PHENYLALANYL-N~5~-[(2,2-DIHYDROXYHYDRAZINO)(IMINO)METHYL]-D-ORNITHINAMIDE	A,B	1RS9	0.75
EJ5	4-[3-(2-amino-4-hydroxy-6-oxo-1,6-dihydropyrimidin-5-yl)propyl]benzoic acid	X	3EJ5	0.71
BAU	1-((2-HYDROXYETHOXY)METHYL)-5-BENZYLPYRIMIDINE-2,4(1H,3H)-DIONE	A,B,C,D,E,F	1U1C	0.7
BAU	1-((2-HYDROXYETHOXY)METHYL)-5-BENZYLPYRIMIDINE-2,4(1H,3H)-DIONE	A,B,C,D	3EUF	0.7
87Y	7,8-DIHYDRO-6-HYDROXYMETHYL-7-METHYL-7-[2-PHENYLETHYL]-PTERIN	A	1DY3	0.73
BFB	N-[(1S)-1-(AMINOCARBONYL)-4-(ETHANIMIDOYLAMINO)BUTYL]BENZAMIDE	A	2DW5	0.75
0Z6	D-phenylalanyl-N-[(1S)-4-{[amino(iminio)methyl]amino}-1-(chloroacetyl)butyl]-L-phenylalaninamide	H,L	3ELA	0.73
MKC	6-BENZYL-1-ETHOXYMETHYL-5-ISOPROPYL URACIL	A	1RT1	0.75
WRG	N~2~-acetyl-N~5~-[N-(methylcarbamoyl)carbamimidoyl]-L-ornithyl-N-methyl-L-phenylalanine	A,B	3CHD	0.72
CHY	CHYMOSTATIN	A,B	1M21	0.7
CHY	CHYMOSTATIN	A,B	1WVM	0.7
AQO	2-AMINOQUINAZOLIN-4(3H)-ONE	A	1S39	0.73
X9Q	{(2S)-2-[(1S)-1-AMINOETHYL]-4-BENZYL-5-OXO-2,5-DIHYDRO-1H-IMIDAZOL-1-YL}ACETIC ACID	A	2HGD	0.71
TTX	TENTOXIN	B	1KMH	0.75
BAG	N-[(E)-2-AMINO-1-(3-{[AMINO(IMINO)METHYL]AMINO}PROPYL)-2-HYDROXYVINYL]BENZAMIDE	A	1WDA	0.75
MAQ	2-AMINO-8-METHYLQUINAZOLIN-4(3H)-ONE	A	1S38	0.71
GCA	6-(3',5'-DIMETHYLBENZYL)-1-ETHOXYMETHYL-5-ISOPROPYLURACIL	A	1C1B	0.73
44U	beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide	B,D	3DA9	0.7
DI4	AC-(D)PHE-PRO-BOROHOMOLYS-OH	H	1LHF	0.71
V15	2-AMINO-6-(2-PHENYLETHYL)PYRIMIDIN-4(3H)-ONE	A	2V00	0.84
L86	(11S)-11-BENZYL-6-CHLORO-1,2,10,11,12,13,14,15,16,17,18,19-DODECAHYDRO-5,9-METHANO-2,5,8,10,13,17-BENZOHEXAAZACYCLOHENICOSINE-3,24-DIONE	A,B	1NM6	0.7
DP7	AC-(D)PHE-PRO-BOROARG-OH	H	1LHC	0.76
FA4	SM-25453	A,B	2D1O	0.75
FA4	SM-25453	A,B	2D1N	0.75
DI3	AC-(D)PHE-PRO-BORO-N-BUTYL-AMIDINO-GLYCINE-OH	H	1LHE	0.71
DI2	AC-(D)PHE-PRO-BOROLYS-OH	H	1LHD	0.71